Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR342434 vs Humalog in T2DM
NCT02294474Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2015
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jan 2015; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02294474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294474.